Induction of long-term memory CD8+ T cells for recall of viral clearing responses against influenza virus

Journal of Virology

Volumn 76, Issue 9, 2002, Pages 4212-4221

  Deliyannis, Georgia ^a   Jackson, David C ^a   Ede, Nicholas J ^a   Zeng, Weiguang ^a   Hourdakis, Irene ^a   Sakabetis, Evaline ^a   Brown, Lorena E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; LIPOPEPTIDE; PALMITIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; INFLUENZA VIRUS; LONG TERM MEMORY; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECALL; VIRUS TITRATION;

ANIMALS; HUMANS; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LIPOPROTEINS; LUNG; MICE; MICE, INBRED BALB C; NUCLEOPROTEINS; PEPTIDE FRAGMENTS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0036229655     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.9.4212-4221.2002     Document Type: Article

References (51)

1. Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide
2. Cell-mediated immune responses to influenza virus antigens expressed by vaccinia virus recombinants
3. The roles of influenza virus haemagglutinin and nucleoprotein in protection: Analysis using vaccinia virus recombinants
4. + T lymphocyte activation
5. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees
6. Enhanced recognition of a modified peptide antigen by cytotoxic T cells specific for influenza nucleoprotein
7. Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocytes. Comparison of the costimulating support provided by helper T cells and lipoamino acid
8. Simian immunodeficiency virus as a model for vaccination against HIV. Induction in rhesus macaques of GAG- or NEF-specific cytotoxic T lymphocytes by lipopeptides
9. Comparative efficiency of simple lipopeptide constructs for in vivo induction of virus-specific CTL
10. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine
11. + T cell help
12. Disquisitions on original antigenic sin. I. Evidence in man
13. Priming of influenza virus-specific cytotoxic T lymphocytes vivo by short synthetic peptides
14. Mice lacking the transcription factor subunit Rel can clear an influenza infection and have functional anti-viral cytotoxic T cells but do not develop an optimal antibody response
15. + cytotoxic T lymphocytes towards soluble antigens: Immunostimulating-ovalbumin complexes enter the class 1 MHC-restricted antigen pathway and allow sensitization against the immunodominant peptide
16. Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptides
17. Vaccinia virus vectors: New strategies for producing recombinant vaccines
18. + T cells within the light chain of the H3 hemagglutinin molecule of influenza virus
19. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide
20. Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge
21. The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection
22. Extension of HLA-A*0201- restricted minimal epitope by N-εe-palmitoyl-lysine increases the life span of functional presentation to cytotoxic T cells
23. Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein
24. Introduction of soluble protein into the class I pathway of antigen processing and presentation
25. Novel adjuvants and vaccine delivery systems
26. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
27. Priming for in vitro and in vivo anti-human T lymphotropic virus type 1 cellular immunity by virus-related protein reconstituted into liposome
28. Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses
29. Protection against lethal viral infection by vaccination with nonimmunodominant peptides
30. Visualizing the generation of memory CD4 T cells in the whole body
31. + T-cell responses in CD4-depleted Ig(-/-) mice
32. Effects of influenza virus-specific cytotoxic T-lymphocyte responses induced by a synthetic nucleoprotein peptide on the survival of mice challenged with a lethal dose of virus
33. Long-lasting anti-viral cytotoxic T lymphocytes induced in vivo with chimeric-multirestricted lipopeptides
34. Influence of strong CD4 epitope on long-term virus-specific cytotoxic T cell responses induced in vivo with peptides
35. Induction of protective cytotoxic T cells to murine cytomegalovirus by using a nonapeptide and a human-compatible adjuvant (Montanide ISA 720)
36. Peptide-induced antiviral protection by cytotoxic T cells
37. A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells
38. Extracellular processing of peptide antigens that bind class I major histocompatibility molecules
39. + CTL in vivo with peptide vaccine constructs
40. + cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs
41. Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens
42. Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo
43. Lipopeptide particles as the immunologically active component of CTL inducing vaccines
44. Heterologous protection against influenza by injection of DNA encoding a viral protein
45. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection
46. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans
47. T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptides
48. Localization of the cell activator lipopeptide in bone marrow-derived macrophages by electron energy loss spectroscopy (EELS)
49. Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes
50. Induction of cytotoxic T lymphocytes in vivo with protein antigen entrapped in membranous vehicles
51. In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides